Paydirt
HOWL
Ticker

Werewolf Therapeutics, Inc.

HOWL · Healthcare · Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's imm…

Werewolf Therapeutics, Inc. (HOWL), in the Healthcare sector, has 13 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 0 purchases and 13 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jun 17 and filed Jun 22. The most active filer was Luke Evnin with 4 filings.

Add to watchlist
Filings, ttm
13
0 buys · 13 sells
Traders, ttm
8
8 insiders
Volume, ttmiDollar value disclosed in the window
$3.1M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Jun 17
Filed Jun 22
ADViAverage daily dollar volume
$290K
market data
Share price · 12M
$0.40 (-78.2%)
$2.19$1.25$0.31Sep 22 2025Feb 27Aug 5

Adjusted for splits and dividends.

Volume by month
$1.2M$618K$0Oct 2024Apr 2025Oct 2025Apr 2026May 2025 · buys $435KOct 2025 · sells $1.0MNov 2025 · sells $1.2MMay 2026 · sells $585KJun 2026 · sells $264K
Buys $435K Sells $3.1M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
LE Luke Evnin Director 4 filings ML MPM BioVentures 2014 LLC 10% owner 2 filings RP Ra Capital Management, L.P. Director 2 filings PK Peter Kolchinsky Director 1 filing ML MPM Asset Management Investors BV2014 LLC 10% owner 1 filing ML MPM BioImpact LLC Other 1 filing ML Mpm Oncology Innovations Fund Lp 10% owner 1 filing RP RA Capital Nexus Fund II, L.P. Director 1 filing
Recent filings
Ra Capital Management, L.P.SALE 10% owner $136K
389,216 sh × $0.35
Exec Jun 17
Filed Jun 22 · 5:30 PM ET Peter KolchinskySALE 10% owner $128K
345,235 sh × $0.37
Exec Jun 9
Filed Jun 11 · 5:30 PM ET Ra Capital Management, L.P.SALE 10% owner $250K
351,514 sh × $0.71
Exec May 8
Filed May 12 · 5:30 PM ET Luke EvninSALE Director $214K
305,741 sh × $0.70
Exec May 8
Filed May 12 · 5:30 PM ET Luke EvninSALE Director $121K
168,262 sh × $0.72
Exec Apr 30
Filed May 4 · 5:30 PM ET MPM BioImpact LLCSALE 10% owner $171K
140,488 sh × $1.22
Exec Nov 4 2025
Filed Nov 6 2025 · 5:30 PM ET MPM BioVentures 2014 LLCSALE 10% owner $171K
140,488 sh × $1.22
Exec Nov 4 2025
Filed Nov 6 2025 · 5:30 PM ET Luke EvninSALE Director $110K
90,164 sh × $1.22
Exec Nov 4 2025
Filed Nov 6 2025 · 5:30 PM ET Mpm Oncology Innovations Fund LpSALE 10% owner $392K
295,043 sh across 3 lots
Exec Oct 30 2025
Filed Nov 3 2025 · 5:30 PM ET MPM Asset Management Investors BV2014 LLCSALE 10% owner $392K
295,043 sh across 3 lots
Exec Oct 30 2025
Filed Nov 3 2025 · 5:30 PM ET UBS Oncology Impact Fund L.P.SALE 10% owner $446K
276,017 sh across 3 lots
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET MPM BioVentures 2014 LLCSALE 10% owner $446K
276,017 sh across 3 lots
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET Luke EvninSALE Director $134K
86,154 sh × $1.55
Exec Oct 29 2025
Filed Oct 29 2025 · 5:30 PM ET RA Capital Nexus Fund II, L.P.PURCHASE Director $435K
483,452 sh across 2 lots
Exec May 12 2025
Filed May 14 2025 · 5:30 PM ET